BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhai X, Yang Z, Liu X, Dong Z, Zhou D. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer. PeerJ 2020;8:e9975. [PMID: 33005492 DOI: 10.7717/peerj.9975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Ge L, Sun Q, Xia L, Xu X. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases. Medicine (Baltimore) 2022;101:e29802. [PMID: 35777029 DOI: 10.1097/MD.0000000000029802] [Reference Citation Analysis]
2 Jiang F, Huang X, Yang X, Zhou H, Wang Y. NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis. Front Oncol 2022;12:795971. [DOI: 10.3389/fonc.2022.795971] [Reference Citation Analysis]
3 Jin Y, Yu J, Jiang Y, Bu J, Zhu T, Gu X, Zhu X. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer. World J Surg Oncol 2022;20:172. [PMID: 35650627 DOI: 10.1186/s12957-022-02636-9] [Reference Citation Analysis]
4 Zhao T, Wang M, Zhao X, Weng S, Qian K, Shi K, Gu Y, Ying W, Qian X, Zhang Y. YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 Pathway. Front Oncol 2022;12:763341. [PMID: 35186724 DOI: 10.3389/fonc.2022.763341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Su H, Fan Y, Wang Z, Jiang L. A comprehensive investigation on pan-cancer impacts of constitutive centromere associated network gene family by integrating multi-omics data: A CONSORT-compliant article. Medicine (Baltimore) 2022;101:e28821. [PMID: 35363173 DOI: 10.1097/MD.0000000000028821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Nirgude S, Desai S, Choudhary B. Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis. Cancer Rep (Hoboken) 2022;:e1596. [PMID: 34981672 DOI: 10.1002/cnr2.1596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lin S, Du J, Hao J, Luo X, Wu H, Zhang H, Zhao X, Xu L, Wang B. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification. Cancer Manag Res 2021;13:8611-27. [PMID: 34815715 DOI: 10.2147/CMAR.S328851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Liu Y, Teng L, Fu S, Wang G, Li Z, Ding C, Wang H, Bi L. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers. BMC Cancer 2021;21:644. [PMID: 34053447 DOI: 10.1186/s12885-021-08318-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]